|
[1]
|
Se Thoe, E., Fauzi, A., Tang, Y.Q., et al. (2021) A Review on Advances of Treatment Modalities for Alzheimer’s Dis-ease. Life Sciences, 276, Article ID: 119129. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Zhang, X.X., Tian, Y., Wang, Z.T., et al. (2021) The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention. The Jour-nal of Prevention of Alzheimer’s Disease, 8, 313-321. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
(2023) 2023 Alzheimer’s Disease Facts and Figures. Alzheimer’s & Dementia, 19, 1598-1695. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Liu, S., Gao, J., Zhu, M., et al. (2020) Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and Treatment. Molecular Neurobiology, 57, 5026-5043. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Escobar, Y.N.H., O’piela, D., Wold, L.E., et al. (2022) Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer’s Disease. Journal of Alzheimer’s Disease, 87, 17-31. [Google Scholar] [CrossRef]
|
|
[6]
|
Wiatrak, B., Balon, K., Jawień, P., et al. (2022) The Role of the Microbi-ota-Gut-Brain Axis in the Development of Alzheimer’s Disease. International Journal of Molecular Sciences, 23, Article 4862. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Cryan, J.F., O’riordan, K.J., Cowan, C.S.M., et al. (2019) The Micro-biota-Gut-Brain Axis. Physiological Reviews, 99, 1877-2013. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Murray, E.R., Kemp, M. and Nguyen, T.T. (2022) The Microbi-ota-Gut-Brain Axis in Alzheimer’s Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions. Archives of Clinical Neuropsychology, 37, 595-607. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Strandwitz, P. (2018) Neurotransmitter Modulation by the Gut Microbi-ota. Brain Research, 1693, 128-133. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Doifode, T., Giridharan, V.V., Generoso, J.S., et al. (2021) The Impact of the Microbiota-Gut-Brain Axis on Alzheimer’s Disease Pathophysiology. Pharmacological Research, 164, Article ID: 105314. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Zhuang, Z.Q., Shen, L.L., Li, W.W., et al. (2018) Gut Microbiota Is Altered in Patients with Alzheimer’s Disease. Journal of Alzheimer’s Disease, 63, 1337-1346. [Google Scholar] [CrossRef]
|
|
[12]
|
Zhang, F., Zhong, R.J., Cheng, C., et al. (2020) New Therapeutics be-yond Amyloid-β and Tau for the Treatment of Alzheimer’s Disease. Acta Pharmacologica Sinica, 42, 1382-1389. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kim, M.S., Kim, Y., Choi, H., et al. (2020) Transfer of a Healthy Microbiota Reduces Amyloid and Tau Pathology in an Alzheimer’s Disease Animal Model. Gut, 69, 283-294. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Dave, B.P., Shah, Y.B., Maheshwari, K.G., et al. (2023) Patho-physiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development. Cellular and Molecular Neurobiology, 43, 3847-3884. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Zhang, S., Wei, D., Lv, S., et al. (2022) Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice. Journal of Alzheimer’s Disease, 89, 955-975. [Google Scholar] [CrossRef]
|
|
[16]
|
Wang, X., Sun, G., Feng, T., et al. (2019) Sodium Oligo-mannate Therapeutically Remodels Gut Microbiota and Suppresses Gut Bacterial Amino Acids-Shaped Neuroinflamma-tion to Inhibit Alzheimer’s Disease Progression. Cell Research, 29, 787-803. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Feng, Y.S., Tan, Z.X., Wu, L.Y., Dong, F. and Zhang, F. (2020) The Involvement of NLRP3 Inflammasome in the Treatment of Alzheimer’s Disease. Ageing Research Reviews, 64, Arti-cle ID: 101192. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Shukla, P.K., Delotterie, D.F., Xiao, J., et al. (2021) Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease. Cells, 10, Article 779. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Sun, J., Zhang, Y., Kong, Y., et al. (2022) Microbiota-Derived Metab-olite Indoles Induced Aryl Hydrocarbon Receptor Activation and Inhibited Neuroinflammation in APP/PS1 Mice. Brain, Behavior, and Immunity, 106, 76-88. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Chen, Y., Xu, J. and Chen, Y. (2021) Regulation of Neurotransmit-ters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients, 13, Article 2099. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Gedankien, T., Tan, R.J., Qasim, S.E., et al. (2023) Acetylcholine Modu-lates the Temporal Dynamics of Human Theta Oscillations during Memory. Nature Communications, 14, Article No. 5283. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Stolzer, I., Scherer, E., Süß, P., et al. (2023) Impact of Micro-biome-Brain Communication on Neuroinflammation and Neurodegeneration. International Journal of Molecular Sciences, 24, Article 14925. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Goyal, D., Ali, S.A. and Singh, R.K. (2021) Emerging Role of Gut Microbiota in Modulation of Neuroinflammation and Neurodegeneration with Emphasis on Alzheimer’s Disease. Pro-gress in Neuro-Psychopharmacology and Biological Psychiatry, 106, Article ID: 110112. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
El Sayed, N.S., Kandil, E.A. and Ghoneum, M.H. (2021) En-hancement of Insulin/PI3K/Akt Signaling Pathway and Modulation of Gut Microbiome by Probiotics Fermentation Technology, a Kefir Grain Product, in Sporadic Alzheimer’s Disease Model in Mice. Frontiers in Pharmacology, 12, Article 666502. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Chen, D., Yang, X., Yang, J., et al. (2017) Prebi-otic Effect of Fructooligosaccharides from Morinda officinalis on Alzheimer’s Disease in Rodent Models by Targeting the Microbiota-Gut-Brain Axis. Frontiers in Aging Neuroscience, 9, Article 309582. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Mayer, E.A., Nance, K. and Chen, S. (2022) The Gut-Brain Axis. Annual Review of Medicine, 73, 439-453. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Morris, G., Fernandes, B.S., Puri, B.K., et al. (2018) Leaky Brain in Neurological and Psychiatric Disorders: Drivers and Consequences. Australian & New Zealand Journal of Psychiatry, 52, 924-948. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Liu, S., Gao, J., Liu, K. and Zhang, H.L. (2021) Microbio-ta-Gut-Brain Axis and Alzheimer’s Disease: Implications of the Blood-Brain Barrier as an Intervention Target. Mecha-nisms of Ageing and Development, 199, Article ID: 111560. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Yang, X., Yu, D., Xue, L., et al. (2020) Probiotics Modulate the Microbiota-Gut-Brain Axis and Improve Memory Deficits in Aged SAMP8 Mice. Acta Pharmaceutica Sinica B, 10, 475-487. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Fasina, O.B., Wang, J., Mo, J., et al. (2022) Gastrodin from Gastrodia elata Enhances Cognitive Function and Neuroprotection of AD Mice via the Regulation of Gut Microbi-ota Composition and Inhibition of Neuron Inflammation. Frontiers in Pharmacology, 13, Article ID: 814271. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Plascencia-Villa, G. and Perry, G. (2023) Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease. Antioxidants, 12, Article 1628. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Bonfili, L., Cecarini, V., Cuccioloni, M., et al. (2018) SLAB51 Pro-biotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Mod-el. Molecular Neurobiology, 55, 7987-8000. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Qiao, L., Chen, Y., Song, X., et al. (2022) Selenium Nanoparti-cles-Enriched Lactobacillus casei ATCC 393 Prevents Cognitive Dysfunction in Mice Through Modulating Microbio-ta-Gut-Brain Axis. International Journal of Nanomedicine, 17, 4807-4827. [Google Scholar] [CrossRef]
|
|
[34]
|
Weng, M.H., Chen, S.Y., Li, Z.Y., et al. (2020) Camellia Oil Alleviates the Progression of Alzheimer’s Disease in Aluminum Chloride-Treated Rats. Free Radical Biology and Medicine, 152, 411-421. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Espín, J.C., González-Sarrías, A. and Tomás-Barberán, F.A. (2017) The Gut Microbiota: A Key Factor in the Therapeutic Effects of (Poly) Phenols. Biochemical Pharmacology, 139, 82-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Hu, B., Shi, Y., Lu, C., et al. (2023) Raspberry Poly-phenols Alleviate Neurodegenerative Diseases: Through Gut Microbiota and ROS Signals. Food & Function, 14, 7760-7779. [Google Scholar] [CrossRef]
|